Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
404-04-002 ISMRM Abstract

Quantitative Susceptibility Mapping-Based Substantia Nigra Volumetry for Differential Diagnosis of Parkinsonism

Primary: Neuro - Parkinson's Disease
Secondary: Contrast Mechanisms - Susceptibility/QSM
404-04-002 · Applications of QSM and Iron in the Brain · Tuesday, 12 May, 4:00 PM–5:50 PM · Ballroom East
Keywords: Differential Diagnosis Quantitative Susceptibility Mapping (QSM) Parkinsonian Syndromes Morphological features Substantia Nigra
Accepted
Huseyin E Candan 1, Sungyang Jo2, Nepes Myratgeldiyev3, Abel W Tessema3,4, Hansol Lee3,5, Jae-Hyeok Lee6, Hyoyoung Lee2, Grace Y Lee7, Chong H Suh8, Jihong Ryu2, Sun J Chung2, Kyemyung Park1,3, Eun-Jae Lee2, HyungJoon Cho3
1Graduate School of Health Science and Technology, Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of
2Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
3Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of
4School of Biomedical Engineering, Jimma University, Jimma Institute of Technology, Jimma, Ethiopia
5Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, United States of America
6Department of Neurology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea, Republic of
7Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
8Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Presenting Author: Huseyin E Candan

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Bloem BR, Okun MS and Klein C. Parkinson's disease. The Lancet 2021; 397: 2284-2303.
2. Gibb W and Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 1988; 51: 745-752.
3. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders 2015; 30: 1591-1601. DOI: https://doi.org/10.1002/mds.26424. [doi]
4. Poewe W, Stankovic I, Halliday G, et al. Multiple system atrophy. Nature Reviews Disease Primers 2022; 8: 56. DOI: 10.1038/s41572-022-00382-6. [doi]
5. Boxer AL, Yu J-T, Golbe LI, et al. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. The Lancet Neurology 2017; 16: 552-563. DOI: 10.1016/S1474-4422(17)30157-6. [doi]
6. Hughes AJ, Daniel SE, Ben‐Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861-870. DOI: 10.1093/brain/awf080. [doi]
7. Rizzo G, Copetti M, Arcuti S, et al. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 2016; 86: 566-576.
8. Koga S, Aoki N, Uitti RJ, et al. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 2015; 85: 404-412.
9. Heim B, Krismer F, De Marzi R, et al. Magnetic resonance imaging for the diagnosis of Parkinson’s disease. Journal of Neural Transmission 2017; 124: 915-964. DOI: 10.1007/s00702-017-1717-8. [doi]
10. Massey LA, Micallef C, Paviour DC, et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders 2012; 27: 1754-1762. DOI: https://doi.org/10.1002/mds.24968. [doi]
11. Stamelou M, Knake S, Oertel WH, et al. Magnetic resonance imaging in progressive supranuclear palsy. Journal of Neurology 2011; 258: 549-558. DOI: 10.1007/s00415-010-5865-0. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/404-04-002